Package 69097-071-12

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 69097-071-12
Digits Only 6909707112
Product NDC 69097-071
Product ID 69097-071_9c292b5a-2a09-4f01-b1fe-8652dd577542
Description

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-071-12)

Marketing

Marketing Status
Marketed Since 2023-10-25
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9c292b5a-2a09-4f01-b1fe-8652dd577542", "openfda": {"upc": ["0369097072124", "0369097071127"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["0abd64f7-5142-48f6-a487-3f5bdc3400de"], "manufacturer_name": ["Cipla USA., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69097-071-12)", "package_ndc": "69097-071-12", "marketing_start_date": "20231025"}], "brand_name": "Bupropion Hydrochloride", "product_id": "69097-071_9c292b5a-2a09-4f01-b1fe-8652dd577542", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69097-071", "generic_name": "Bupropion hydrochloride", "labeler_name": "Cipla USA., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20231025", "listing_expiration_date": "20261231"}